What is the global market size of Dry Eye Syndrome Treatment Market?

Global Dry Eye Syndrome Treatment Market size was valued at USD 7.07 billion in 2023 and is poised to grow from USD 7.56 billion in 2024 to USD 13.0 billion by 2032, growing at a CAGR of 7.0% during the forecast period (2025-2032).

Top Dry Eye Syndrome Treatment Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Dry Eye Syndrome Treatment Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Dry Eye Syndrome Treatment industry players.

Dry Eye Syndrome Treatment Market Competitive Landscape

Top Players in Dry Eye Syndrome Treatment Market

Novartis AG (Switzerland)
AbbVie Inc. (USA)
Sun Pharmaceutical Industries Ltd. (India)
Santen Pharmaceutical Co. Ltd. (Japan)
AFT Pharmaceuticals (New Zealand)
Johnson & Johnson Services, Inc. (USA)
Otsuka Pharmaceutical Co. Ltd. (Japan)
OASIS Medical (USA)
Bausch Health Companies Inc. (Canada)
Alcon Inc. (Switzerland)
Akorn Operating Company LLC (USA)
Alimera Sciences (USA)
GlaxoSmithKline plc (UK)
Nicox S.A. (France)
Novaliq GmbH (Germany)
Horus Pharma (France)
Mitotech (Russia)
Prestige Consumer Healthcare (USA)
Sentiss Pharma Pvt. Ltd. (India)
VISUfarma (Netherlands)

Dry Eye Syndrome Treatment Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?

REQUEST FREE CUSTOMIZATION

FAQs

Global Dry Eye Syndrome Treatment Market size was valued at USD 7.56 Billion in 2024 and is poised to grow from USD 8.09 Billion in 2025 to USD 13.9 Billion by 2033, growing at a CAGR of 7% during the forecast period (2026–2033).

The global dry eye syndrome treatment market is characterized by intense competition among key players striving to gain a competitive edge. Established pharmaceutical companies and innovative biotech firms are engaged in continuous research and development to introduce advanced therapies and novel treatment options. Additionally, strategic collaborations, mergers, and acquisitions are prevalent in the market to expand product portfolios and enhance global market presence. Factors such as rising awareness of dry eye syndrome, an aging population, and technological advancements contribute to the market's growth, fostering a highly competitive landscape focused on addressing patient needs effectively. 'Novartis AG (Switzerland) ', 'AbbVie Inc. (USA) ', 'Sun Pharmaceutical Industries Ltd. (India) ', 'Santen Pharmaceutical Co. Ltd. (Japan) ', 'AFT Pharmaceuticals (New Zealand) ', 'Johnson & Johnson Services, Inc. (USA) ', 'Otsuka Pharmaceutical Co. Ltd. (Japan) ', 'OASIS Medical (USA) ', 'Bausch Health Companies Inc. (Canada) ', 'Alcon Inc. (Switzerland) ', 'Akorn Operating Company LLC (USA) ', 'Alimera Sciences (USA) ', 'GlaxoSmithKline plc (UK) ', 'Nicox S.A. (France) ', 'Novaliq GmbH (Germany) ', 'Horus Pharma (France) ', 'Mitotech (Russia) ', 'Prestige Consumer Healthcare (USA) ', 'Sentiss Pharma Pvt. Ltd. (India) ', 'VISUfarma (Netherlands)'

The growing prevalence of dry eye syndrome (DES) worldwide is a significant driver propelling the growth of the global dry eye syndrome treatment market. Factors such as increasing screen time due to digitalization, aging population, environmental pollution, and lifestyle changes have contributed to a higher incidence of DES. As a result, there is a rising demand for effective and innovative treatment options, including artificial tears, anti-inflammatory medications, and punctal plugs, driving the market's expansion.

There was a growing preference for preservative-free eye drops and artificial tears due to increased awareness about potential side effects of preservatives.

North America dominated the market due to high awareness, advanced healthcare infrastructure, and a large patient pool. Europe followed closely, driven by an aging population and increasing prevalence of dry eye cases.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Luca Giovannini, Marketing Innovation Senior Manager, Trelleborg.

Dry Eye Syndrome Treatment Market

Report ID: SQMIG35D2131

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE

Top Dry Eye Syndrome Treatment Companies

Dry Eye Syndrome Treatment Market Competitive Landscape

Top Players in Dry Eye Syndrome Treatment Market

Dry Eye Syndrome Treatment Market

FAQs

What is the global market size of Dry Eye Syndrome Treatment Market?

Who are the key vendors in the Dry Eye Syndrome Treatment Market?

What is the key driver of Dry Eye Syndrome Treatment Market?

What is the key market trend for Dry Eye Syndrome Treatment Market?

Which region accounted for the largest share in Dry Eye Syndrome Treatment Market?

Request Free Customization